EP0537247A4 - Nonpathogenic variant virus - Google Patents
Nonpathogenic variant virusInfo
- Publication number
- EP0537247A4 EP0537247A4 EP19910912526 EP91912526A EP0537247A4 EP 0537247 A4 EP0537247 A4 EP 0537247A4 EP 19910912526 EP19910912526 EP 19910912526 EP 91912526 A EP91912526 A EP 91912526A EP 0537247 A4 EP0537247 A4 EP 0537247A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- variant virus
- nonpathogenic variant
- nonpathogenic
- virus
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54052990A | 1990-06-19 | 1990-06-19 | |
| US540529 | 1990-06-19 | ||
| US62595890A | 1990-12-11 | 1990-12-11 | |
| US625958 | 1990-12-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0537247A1 EP0537247A1 (en) | 1993-04-21 |
| EP0537247A4 true EP0537247A4 (en) | 1993-09-08 |
Family
ID=27066463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19910912526 Withdrawn EP0537247A4 (en) | 1990-06-19 | 1991-06-19 | Nonpathogenic variant virus |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0537247A4 (en) |
| CA (1) | CA2085897A1 (en) |
| WO (1) | WO1991019795A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015661A (en) * | 1994-02-14 | 2000-01-18 | The Macfarlane Burnet Centre For Medical Research Limited | Methods for the detection of non-pathogenic HIV-1 strains containing deletions in the Nef coding region and U3 region of the LTR |
| AU699175B2 (en) * | 1994-02-14 | 1998-11-26 | Australian Red Cross Society (Nsw Division) | Non-pathogenic strains of HIV-1 |
| IL112636A0 (en) * | 1994-02-14 | 1995-05-26 | Macfarlane Burnet Ctre Med Res | Non-pathogenic strains of hiv-1 |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
| US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| MY139983A (en) | 2002-03-12 | 2009-11-30 | Janssen Alzheimer Immunotherap | Humanized antibodies that recognize beta amyloid peptide |
| WO2006066089A1 (en) | 2004-12-15 | 2006-06-22 | Neuralab Limited | Humanized amyloid beta antibodies for use in improving cognition |
| US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
| US8003097B2 (en) | 2007-04-18 | 2011-08-23 | Janssen Alzheimer Immunotherapy | Treatment of cerebral amyloid angiopathy |
| ES2498040T3 (en) | 2007-07-27 | 2014-09-24 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases with humanized anti-beta antibodies |
| JO3076B1 (en) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | Immunotherapy regimes dependent on apoe status |
| US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU594444B2 (en) * | 1986-02-14 | 1990-03-08 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Plasmids which inhibit human t-cell lymphotropic virus type iii replication |
| EP0242216A1 (en) * | 1986-04-16 | 1987-10-21 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Non-cytopathic clone of Human T-Cell Lymphotropic Virus type III |
| JPH01120284A (en) * | 1987-11-05 | 1989-05-12 | Shiro Kato | Incomplete particle of hiv and production thereof |
| IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
| JPH02203783A (en) * | 1989-02-02 | 1990-08-13 | Banyu Pharmaceut Co Ltd | Cloned human t cell forming non-virulent aids virus having antigenicity |
-
1991
- 1991-06-19 WO PCT/US1991/004374 patent/WO1991019795A1/en not_active Ceased
- 1991-06-19 EP EP19910912526 patent/EP0537247A4/en not_active Withdrawn
- 1991-06-19 CA CA002085897A patent/CA2085897A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1991019795A1 (en) | 1991-12-26 |
| EP0537247A1 (en) | 1993-04-21 |
| CA2085897A1 (en) | 1991-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU111085S (en) | Sunlounger | |
| GB2248044B (en) | Improved doll-carriages | |
| HU910958D0 (en) | Bacteria-vectors | |
| EP0448099A3 (en) | Novel peptides | |
| GB9102066D0 (en) | An improved ozonier | |
| EP0537247A4 (en) | Nonpathogenic variant virus | |
| AU110900S (en) | Facsimilie | |
| CS262591A3 (en) | Indolonaphthyridines | |
| GB2272483B (en) | Stays | |
| GB2249343B (en) | Stays | |
| ZA915978B (en) | Peptides | |
| GB2248607B (en) | Improved fishbox | |
| GB9005419D0 (en) | Improved depanner | |
| AU109294S (en) | Listello | |
| GB9100998D0 (en) | Boardgame | |
| GB9007724D0 (en) | Novel piperidin-4-spiro-oxiranes | |
| GB9020800D0 (en) | Virus attenuation | |
| CA66168S (en) | Récipient | |
| CA65360S (en) | Stomatologic electroanesthetizer | |
| CA65836S (en) | Attache-case | |
| GB9028140D0 (en) | Peptides | |
| GB9013944D0 (en) | Improved airfreshener | |
| SG24194G (en) | Improved fishbox | |
| GB9105801D0 (en) | Instant photograph-postcard | |
| GB9103366D0 (en) | Instant photograph-postcard |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19930118 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19930720 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
| 17Q | First examination report despatched |
Effective date: 19950316 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19960101 |